Tarsus Pharmaceuticals Statistics
Total Valuation
TARS has a market cap or net worth of $2.84 billion. The enterprise value is $2.48 billion.
| Market Cap | 2.84B |
| Enterprise Value | 2.48B |
Important Dates
The last earnings date was Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TARS has 43.88 million shares outstanding. The number of shares has increased by 7.95% in one year.
| Current Share Class | 43.88M |
| Shares Outstanding | 43.88M |
| Shares Change (YoY) | +7.95% |
| Shares Change (QoQ) | +1.02% |
| Owned by Insiders (%) | 3.20% |
| Owned by Institutions (%) | 84.00% |
| Float | 32.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 177.88 |
| PS Ratio | 4.69 |
| Forward PS | 3.56 |
| PB Ratio | 8.09 |
| P/TBV Ratio | 8.37 |
| P/FCF Ratio | 50.77 |
| P/OCF Ratio | 38.34 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 44.32 |
Financial Position
The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.26.
| Current Ratio | 3.20 |
| Quick Ratio | 3.12 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.59 |
| Interest Coverage | -5.54 |
Financial Efficiency
Return on equity (ROE) is -13.68% and return on invested capital (ROIC) is -7.22%.
| Return on Equity (ROE) | -13.68% |
| Return on Assets (ROA) | -5.48% |
| Return on Invested Capital (ROIC) | -7.22% |
| Return on Capital Employed (ROCE) | -11.15% |
| Weighted Average Cost of Capital (WACC) | 7.09% |
| Revenue Per Employee | $1.64M |
| Profits Per Employee | -$125,611 |
| Employee Count | 370 |
| Asset Turnover | 1.10 |
| Inventory Turnover | 25.47 |
Taxes
In the past 12 months, TARS has paid $7.13 million in taxes.
| Income Tax | 7.13M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.60% in the last 52 weeks. The beta is 0.51, so TARS's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +55.60% |
| 50-Day Moving Average | 61.20 |
| 200-Day Moving Average | 68.42 |
| Relative Strength Index (RSI) | 59.88 |
| Average Volume (20 Days) | 1,007,197 |
Short Selling Information
The latest short interest is 5.78 million, so 13.18% of the outstanding shares have been sold short.
| Short Interest | 5.78M |
| Short Previous Month | 5.89M |
| Short % of Shares Out | 13.18% |
| Short % of Float | 17.67% |
| Short Ratio (days to cover) | 4.26 |
Income Statement
In the last 12 months, TARS had revenue of $606.33 million and -$46.48 million in losses. Loss per share was -$1.08.
| Revenue | 606.33M |
| Gross Profit | 501.26M |
| Operating Income | -48.54M |
| Pretax Income | -39.35M |
| Net Income | -46.48M |
| EBITDA | -46.20M |
| EBIT | -48.54M |
| Loss Per Share | -$1.08 |
Balance Sheet
The company has $449.69 million in cash and $88.81 million in debt, with a net cash position of $360.88 million or $8.22 per share.
| Cash & Cash Equivalents | 449.69M |
| Total Debt | 88.81M |
| Net Cash | 360.88M |
| Net Cash Per Share | $8.22 |
| Equity (Book Value) | 346.73M |
| Book Value Per Share | 8.01 |
| Working Capital | 386.24M |
Cash Flow
In the last 12 months, operating cash flow was $74.16 million and capital expenditures -$18.16 million, giving a free cash flow of $56.00 million.
| Operating Cash Flow | 74.16M |
| Capital Expenditures | -18.16M |
| Depreciation & Amortization | 2.34M |
| Net Borrowing | n/a |
| Free Cash Flow | 56.00M |
| FCF Per Share | $1.28 |
Margins
Gross margin is 82.67%, with operating and profit margins of -8.00% and -7.67%.
| Gross Margin | 82.67% |
| Operating Margin | -8.00% |
| Pretax Margin | -6.49% |
| Profit Margin | -7.67% |
| EBITDA Margin | -7.62% |
| EBIT Margin | -8.00% |
| FCF Margin | 9.24% |
Dividends & Yields
TARS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.95% |
| Shareholder Yield | -7.95% |
| Earnings Yield | -1.63% |
| FCF Yield | 1.97% |
Analyst Forecast
The average price target for TARS is $94.25, which is 45.08% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $94.25 |
| Price Target Difference | 45.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 30.36% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TARS has an Altman Z-Score of 6.66 and a Piotroski F-Score of 3.
| Altman Z-Score | 6.66 |
| Piotroski F-Score | 3 |